Avanos Medical Balance Sheet Health
Financial Health criteria checks 6/6
Avanos Medical has a total shareholder equity of $1.2B and total debt of $162.0M, which brings its debt-to-equity ratio to 13.2%. Its total assets and total liabilities are $1.7B and $426.5M respectively. Avanos Medical's EBIT is $56.3M making its interest coverage ratio 7.6. It has cash and short-term investments of $89.0M.
Key information
13.2%
Debt to equity ratio
US$162.00m
Debt
| Interest coverage ratio | 7.6x |
| Cash | US$89.00m |
| Equity | US$1.23b |
| Total liabilities | US$426.50m |
| Total assets | US$1.66b |
Recent financial health updates
Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05
We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Recent updates
Avanos Medical, Inc.'s (NYSE:AVNS) Price Is Right But Growth Is Lacking
Oct 25There May Be Some Bright Spots In Avanos Medical's (NYSE:AVNS) Earnings
Aug 07Lacklustre Performance Is Driving Avanos Medical, Inc.'s (NYSE:AVNS) Low P/S
Apr 17Is Avanos Medical (NYSE:AVNS) A Risky Investment?
Jan 05Some Avanos Medical, Inc. (NYSE:AVNS) Analysts Just Made A Major Cut To Next Year's Estimates
Aug 14When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
Aug 13Avanos Medical: Leaning Up, Attractive Returns On Incremental Capital, Reiterate Buy
Jul 16We Think Avanos Medical (NYSE:AVNS) Can Manage Its Debt With Ease
Jun 05Avanos Medical, Inc. (NYSE:AVNS) Stocks Pounded By 26% But Not Lagging Market On Growth Or Pricing
May 18Avanos Medical (NYSE:AVNS) Is Looking To Continue Growing Its Returns On Capital
May 07Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
Mar 02Avanos Medical Q4 2022 Earnings Preview
Feb 20Avanos Medical, Inc. (NYSE:AVNS) Shares Could Be 30% Below Their Intrinsic Value Estimate
Feb 10Why Avanos Medical, Inc. (NYSE:AVNS) Could Be Worth Watching
Jan 13Avanos Medical reports Q3 mixed earnings; reaffirms FY22 guidance
Nov 02Avanos: Recent Entry To Hyaluronic Acid Market Sparks Interesting Debate
Sep 12Avanos Medical Q2 2022 Earnings Preview
Aug 08When Should You Buy Avanos Medical, Inc. (NYSE:AVNS)?
May 28Is Avanos Medical (NYSE:AVNS) Using Too Much Debt?
May 03Is There An Opportunity With Avanos Medical, Inc.'s (NYSE:AVNS) 41% Undervaluation?
Feb 10Should You Think About Buying Avanos Medical, Inc. (NYSE:AVNS) Now?
Dec 21An Intrinsic Calculation For Avanos Medical, Inc. (NYSE:AVNS) Suggests It's 33% Undervalued
Nov 04Financial Position Analysis
Short Term Liabilities: AVNS's short term assets ($472.6M) exceed its short term liabilities ($212.9M).
Long Term Liabilities: AVNS's short term assets ($472.6M) exceed its long term liabilities ($213.6M).
Debt to Equity History and Analysis
Debt Level: AVNS's net debt to equity ratio (5.9%) is considered satisfactory.
Reducing Debt: AVNS's debt to equity ratio has reduced from 19.6% to 13.2% over the past 5 years.
Debt Coverage: AVNS's debt is well covered by operating cash flow (34.3%).
Interest Coverage: AVNS's interest payments on its debt are well covered by EBIT (7.6x coverage).